Filing Details
- Accession Number:
- 0001127602-15-005509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-11 16:26:48
- Reporting Period:
- 2015-02-10
- Filing Date:
- 2015-02-11
- Accepted Time:
- 2015-02-11 16:26:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1577061 | Alfred Sandrock | Biogen Idec Inc. 225 Binney Street Cambridge MA 02142 | Grp Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-10 | 300 | $397.11 | 15,417 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-10 | 643 | $398.10 | 14,774 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-10 | 100 | $399.08 | 14,674 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-10 | 100 | $400.22 | 14,574 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $396.87 (low) and $397.34 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $397.94 (low) and $398.65 (high).